PE20050901A1 - COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE - Google Patents
COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULEInfo
- Publication number
- PE20050901A1 PE20050901A1 PE2004001213A PE2004001213A PE20050901A1 PE 20050901 A1 PE20050901 A1 PE 20050901A1 PE 2004001213 A PE2004001213 A PE 2004001213A PE 2004001213 A PE2004001213 A PE 2004001213A PE 20050901 A1 PE20050901 A1 PE 20050901A1
- Authority
- PE
- Peru
- Prior art keywords
- atenolol
- amlodipine
- capsule
- pharmaceutical form
- combination
- Prior art date
Links
Abstract
REFERIDA A UNA COMBINACION FARMACEUTICA BAJO LA FORMA FARMACEUTICA DE CAPSULA CUYOS PRINCIPIOS ACTIVOS SON: A) UN ANTAGONISTA DE LOS CANALES DE CALCIO COMO AMLODIPINA, Y B) UN BETABLOQUEADOR TAL COMO ATENOLOL GRANULADO QUE SE HALLA DENTRO DE UNA CAPSULA DE GELATINA DURA. A Y B SE HALLAN EN LA COMPOSICION DE 5-20 mg Y DE 20-100 mg RESPECTIVAMENTE. DICHA COMPOSICION ES UTIL EN LA HIPERTENSION ARTERIAL Y EN LA INSUFICIENCIA CORONARIA CRONICA ESTABLEREFERRING TO A PHARMACEUTICAL COMBINATION IN THE PHARMACEUTICAL FORM OF CAPSULE WHOSE ACTIVE PRINCIPLES ARE: A) AN ANTAGONIST OF CALCIUM CHANNELS SUCH AS AMLODIPINE, AND B) A BETABLOCKER SUCH AS ATENOLOL GRANULATED THAT IS FOUND INSIDE A GATIN CAPSULA. A AND B ARE IN THE COMPOSITION OF 5-20 mg AND 20-100 mg, RESPECTIVELY. SUCH COMPOSITION IS USEFUL IN ARTERIAL HYPERTENSION AND IN STABLE CHRONIC CORONARY INSUFFICIENCY
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0304956-6A BR0304956A (en) | 2003-12-09 | 2003-12-09 | Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20050901A1 true PE20050901A1 (en) | 2005-12-16 |
Family
ID=35295191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2004001213A PE20050901A1 (en) | 2003-12-09 | 2004-12-09 | COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR046876A1 (en) |
BR (1) | BR0304956A (en) |
CO (1) | CO5650066A1 (en) |
EC (1) | ECSP045478A (en) |
MX (1) | MXPA04012380A (en) |
PE (1) | PE20050901A1 (en) |
-
2003
- 2003-12-09 BR BR0304956-6A patent/BR0304956A/en not_active IP Right Cessation
-
2004
- 2004-12-08 EC ECSP045478 patent/ECSP045478A/en unknown
- 2004-12-09 CO CO04123478A patent/CO5650066A1/en not_active Application Discontinuation
- 2004-12-09 MX MXPA04012380 patent/MXPA04012380A/en not_active Application Discontinuation
- 2004-12-09 AR ARP040104581 patent/AR046876A1/en not_active Application Discontinuation
- 2004-12-09 PE PE2004001213A patent/PE20050901A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR0304956A (en) | 2005-11-08 |
CO5650066A1 (en) | 2006-06-30 |
MXPA04012380A (en) | 2005-10-19 |
ECSP045478A (en) | 2006-09-18 |
AR046876A1 (en) | 2005-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR7074A (en) | MERCAPTOACETYLAMIDA DERIVATIVES AND PROCESS FOR PREPARATION AND USE | |
DK1575566T3 (en) | Multilayer dosage forms containing naproxen and triptans | |
BRPI0513841A (en) | compound, pharmaceutical composition, and compound use | |
EA201070835A1 (en) | COMPOSITION CAPSULES | |
CO6160321A2 (en) | USE OF 2-6- (3-AMINO-PIPERIDIN-1-IL) -3-METIL-2,4-DIOXO-3,4-DIHIDRO-2H-PYRIMIDIN-1-ILMETIL-4-FLUORO-BENZONITRILE | |
CR9262A (en) | FORMULATIONS IN TABLET OF CCI-1179 ORALY AVAILABLE | |
ECSP088549A (en) | NEW DERIVATIVES OF FUSIONATED PIRROL | |
ECSP12006640A (en) | ASPARTIL PROTEASA HETEROCYCLIC INHIBITORS | |
ECSP066534A (en) | DOSAGE FORMS OF CONTROLLED OXYCODONE, ORALS, ONCE A DAY | |
HN2009000785A (en) | DOSAGE FORMS OF PALONOSETRON CHLORHYDRATE THAT HAVE IMPROVED STABILITY AND BIODISPONIBILITY | |
PE20091809A1 (en) | USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR MORTALITY | |
PA8809601A1 (en) | ANTI-RETROVIRAL COMBINATION | |
EA201691869A1 (en) | STABLE COMBINED PHARMACEUTICAL COMPOSITION | |
BR0009674A (en) | Compound, drug and compound use | |
ECSP066872A (en) | DISINTEGRANT TABLETS UNDERSTANDING LICARBAZEPINA | |
IS7394A (en) | Stable drug formulations | |
PE20050901A1 (en) | COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE | |
PE20110116A1 (en) | ASSOCIATION OF IVABRADINE AND PERINDOPRIL AND THE PHARMACEUTICAL COMPOSITION CONTAINING IT | |
CL2012002341A1 (en) | Oral solid pharmaceutical composition comprising ramipril and amlodipine besylate; preparation procedure; use in the treatment of hypertension and prevention of myocardial infarction, cerebrovascular and cardiac disorders and renal insufficiency. | |
CR9406A (en) | DDGS AS A LOW COST FLAVOR ACUTOR AND SODIUM REDUCTION ENABLE | |
CR8948A (en) | PHARMACEUTICAL COMPOSITION | |
AR050627A1 (en) | PHARMACEUTICAL COMPOSITION | |
CR6505A (en) | SUBSTITUTED BENZOLACTAMA COMPOUNDS | |
EA201291420A1 (en) | ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | |
UY28857A1 (en) | 17A (ALPHA) -FLUOROSTEROIDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |